litlas
Log inCreate account

Massimo Federico

Active 1985–2025

99
Papers
22,401
Citations
73
h-index
95
i10-index

Citations

Citations per year for Massimo Federico1987: 1 citations1991: 1 citations1995: 1 citations1996: 1 citations1997: 2 citations1998: 4 citations1999: 1 citations2000: 1 citations2001: 10 citations2002: 6 citations2003: 7 citations2004: 17 citations2005: 38 citations2006: 35 citations2007: 61 citations2008: 83 citations2009: 90 citations2010: 105 citations2011: 124 citations2012: 152 citations2013: 152 citations2014: 194 citations2015: 178 citations2016: 164 citations2017: 211 citations2018: 162 citations2019: 693 citations2020: 650 citations2021: 577 citations2022: 406 citations2023: 271 citations2024: 445 citations2025: 143 citations2026: 4 citations1988–1990: no citations, so these years are not shown1992–1994: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,689 citing papers, 20.5% of this breakdownItaly: 682 citing papers, 8.3% of this breakdownFrance: 561 citing papers, 6.8% of this breakdownUnited Kingdom: 528 citing papers, 6.4% of this breakdownGermany: 522 citing papers, 6.3% of this breakdownChina: 388 citing papers, 4.7% of this breakdownCanada: 326 citing papers, 4% of this breakdownSpain: 317 citing papers, 3.8% of this breakdownNetherlands: 300 citing papers, 3.6% of this breakdownSwitzerland: 299 citing papers, 3.6% of this breakdownAustralia: 231 citing papers, 2.8% of this breakdownJapan: 226 citing papers, 2.7% of this breakdown
0%20.5%Other 26.5%

Institutions

Fields

  • Medicine88.1%
  • Biochemistry, Genetics and Molecular Biology7.5%
  • Immunology and Microbiology2.3%
  • Computer Science0.6%
  • Engineering0.4%
  • Materials Science0.2%
  • Other0.9%

Topics

  • Lymphoma Diagnosis and Treatment19.4%
  • CNS Lymphoma Diagnosis and Treatment5.7%
  • Viral-associated cancers and disorders5.7%
  • CAR-T cell therapy research4.9%
  • Chronic Lymphocytic Leukemia Research4.4%
  • Cutaneous lymphoproliferative disorders research3.2%
  • Other56.7%

Coauthors

All papers

Open in search
  1. Revised Response Criteria for Malignant Lymphoma

    Authors: Bruce D. Cheson, Beate Pfistner, Malik E. Juweid, Randy D. Gascoyne, Lena Specht, Sandra J. Horning, Bertrand Coiffier, Richard I. Fisher, Anton Hagenbeek, Emanuele Zucca, Steven T. Rosen, Sigrid Stroobants, T. Andrew Lister, Richard T. Hoppe, Martin Dreyling, Kensei Tobinai, Julie M. Vose, Joseph M. Connors, Massimo Federico, Volker Diehl - Journal of Clinical Oncology 2007 cited by 4,448

  2. Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin’s Lymphoma

    Authors: Peter Johnson, Massimo Federico, Amy A. Kirkwood, Alexander Fosså, Leanne Berkahn, Angelo Michele Carella, Francesco d’Amore, Gunilla Enblad, Antonella Franceschetto, Michael Fulham, Stefano Luminari, Michael O'Doherty, Pip Patrick, Thomas A. Roberts, Gamal Sidra, Lindsey Stevens, Paul Smith, Judith Trotman, Zaid Viney, John Radford, Sally F. Barrington - New England Journal of Medicine 2016 cited by 798

  3. Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project

    Authors: Massimo Federico, Monica Bellei, Luigi Marcheselli, Stefano Luminari, Armando López‐Guillermo, Umberto Vitolo, Barbara Pro, Stefano Pileri, Alessandro Pulsoni, Pierre Soubeyran, Sergio Cortelazzo, Giovanni Martinelli, Maurizio Martelli, Luigi Rigacci, Luca Arcaini, Francesco Di Raimondo, Francesco Merli, Elena Sabattini, Peter McLaughlin, Philippe Solal‐Céligny - Journal of Clinical Oncology 2009 cited by 751

  4. Early Positron Emission Tomography Response–Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial

    Authors: Marc André, T. Girinsky, Massimo Federico, Oumédaly Reman, Catherine Fortpied, Manuel Gotti, Olivier Casasnovas, Pauline Brice, Richard van der Maazen, Alessandro Re, Véronique Edeline, Christophe Fermé, Gustaaf van Imhoff, Francesco Merli, Réda Bouabdallah, Catherine Sebban, Lena Specht, Aspasia Stamatoullas, Richard Delarue, Valeria Fiaccadori, Monica Bellei, Tiana Raveloarivahy, Annibale Versari, Martin Hutchings, Michel Meignan, John Raemaekers - Journal of Clinical Oncology 2017 cited by 532

  5. Randomized Comparison of Gemcitabine, Dexamethasone, and Cisplatin Versus Dexamethasone, Cytarabine, and Cisplatin Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: NCIC-CTG LY.12

    Authors: Michael Crump, John Kuruvilla, Stephen Couban, David MacDonald, Vishal Kukreti, C. Tom Kouroukis, Morel Rubinger, Rena Buckstein, Kevin Imrie, Massimo Federico, Nicola Di Renzo, Kang Howson‐Jan, Tara Baetz, Leonard Kaizer, Michael Voralia, Harold J. Olney, A. Robert Turner, Jonathan Sussman, Annette E. Hay, Marina Djurfeldt, Ralph M. Meyer, Bingshu E. Chen, Lois E. Shepherd - Journal of Clinical Oncology 2014 cited by 463

  6. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts

    Authors: Heikki Joensuu, Aki Vehtari, Jaakko Riihimäki, Toshirou Nishida, Sonja E. Steigen, Peter Brabec, Lukáš Plank, Bengt Nilsson, Claudia Cirilli, Chiara Braconi, Andrea Bordoni, Magnús K. Magnússon, Zdeněk Linke, Jozef Šufliarský, Massimo Federico, Jón G. Jónasson, Angelo Paolo Dei Tos, Piotr Rutkowski - The Lancet Oncology 2011 cited by 1,005

  7. Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: Dennis A. Eichenauer, Berthe M.P. Aleman, M. André, Massimo Federico, Martin Hutchings, Tim Illidge, Andreas Engert, Marco Ladetto - Annals of Oncology 2018 cited by 423

  8. The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project

    Authors: Monica Bellei, Francine M. Foss, Andrei R. Shustov, Steven M. Horwitz, Luigi Marcheselli, Won Seog Kim, María Elena Cabrera, Iván Dlouhy, Arnon Nagler, Ranjana H. Advani, Emanuela Anna Pesce, Young Hyeh Ko, Virginia Martínez, Silvia Montoto, Carlos Chiattone, Alison J. Moskowitz, Michele Spina, Irène Biasoli, Martina Manni, Massimo Federico - Haematologica 2018 cited by 156

  9. Baseline Metabolic Tumor Volume Predicts Outcome in High–Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies

    Authors: Michel Meignan, Anne‐Ségolène Cottereau, Annibale Versari, Loïc Chartier, Jehan Dupuis, Sami Boussetta, Ilaria Grassi, Olivier Casasnovas, Corinne Haïoun, Hervé Tilly, Vittoria Tarantino, Julien Dubreuil, Massimo Federico, Gilles Salles, Stefano Luminari, Judith Trotman - Journal of Clinical Oncology 2016 cited by 337

  10. Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial

    Authors: Viola Poeschel, Gerhard Held, Marita Ziepert, Mathias Witzens‐Harig, Harald Holte, Lorenz Thurner, Peter Borchmann, Andreas Viardot, Martin Soekler, Ulrich Keller, Christian Schmidt, Lorenz Truemper, Rolf Mahlberg, Reinhard Marks, Heinz‐Gert Hoeffkes, Bernd Metzner, Judith Dierlamm, Norbert Frickhofen, Mathias Haenel, Andreas Neubauer, Michael Kneba, Francesco Merli, Alessandra Tucci, Peter de Nully Brown, Massimo Federico, Eva Lengfelder, Alice Di Rocco, Ralf Ulrich Trappe, Andreas Rosenwald, Christian Berdel, Martin Maisenhoelder, Ofer Shpilberg, Josif Amam, Konstantinos Christofyllakis, Frank Hartmann, Niels Murawski, Stephan Stilgenbauer, Maike Nickelsen, Gerald Wulf, Bertram Glaß, Norbert Schmitz, Bettina Altmann, Markus Loeffler, Michael Pfreundschuh - The Lancet 2019 cited by 253

  11. Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group

    Authors: Francesco Sardanelli, C. Boetes, Bettina Borisch, Thomas Decker, Massimo Federico, Fiona J. Gilbert, Thomas H. Helbich, Sylvia H. Heywang‐Köbrunner, Werner A. Kaiser, Michael J. Kerin, Robert E. Mansel, Lorenza Marotti, Laura Martincich, L. Mauriac, Hanne Meijers‐Heijboer, Roberto Orecchia, Pietro Panizza, Antonio Ponti, Arnie Purushotham, Peter Regitnig, Marco Rosselli Del Turco, Fabienne Thibault, Robin Wilson - European Journal of Cancer 2010 cited by 975

  12. International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)

    Authors: Anas Younes, Patrick Hilden, Bertrand Coiffier, Anton Hagenbeek, Gilles Salles, Wyndham H. Wilson, John F. Seymour, Kara M. Kelly, John G. Gribben, M. Pfreunschuh, Franck Morschhauser, Heiko Schöder, Andrew D. Zelenetz, Jürgen Rademaker, Ranjana H. Advani, Nancy Valente, Catherine Fortpied, Thomas E. Witzig, Laurie H. Sehn, Andreas Engert, Richard I. Fisher, Pier Luigi Zinzani, Massimo Federico, Martin Hutchings, Catherine M. Bollard, Marek Trněný, Yusri Elsayed, Kensei Tobinai, Jeremy S. Abramson, Nathan Fowler, André Goy, Mitchell R. Smith, Stephen M. Ansell, John Kuruvilla, Martin Dreyling, Catherine Thiéblemont, Richard F. Little, Igor Aurer, Marinus H. J. van Oers, Kenichi Takeshita, Ajay K. Gopal, Simon Rule, Sven de Vos, Ioana Kloos, Mark Kaminski, Michel Meignan, Lawrence H. Schwartz, John P. Leonard, Stephen J. Schuster, Venkatraman Seshan - Annals of Oncology 2017 cited by 377

  13. Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial

    Authors: Anne‐Ségolène Cottereau, Annibale Versari, Annika Loft, Olivier Casasnovas, Monica Bellei, Romain Ricci, Stéphane Bardet, Antonio Castagnoli, Pauline Brice, John Raemaekers, Bénédicte Deau, Catherine Fortpied, Tiana Raveloarivahy, Emelie Van Zele, Loïc Chartier, Thierry Vander Borght, Massimo Federico, Martin Hutchings, Umberto Ricardi, Marc André, Michel Meignan - Blood 2018 cited by 189

  14. Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis

    Authors: Massimo Federico, María Dolores Caballero Barrigón, Luigi Marcheselli, Vittoria Tarantino, Martina Manni, Clémentine Sarkozy, Sara Alonso, Mariëlle J. Wondergem, Guillaume Cartron, Armando López‐Guillermo, Djamila E. Issa, Franck Morschhauser, Miguel Alcoceba, Eva Kimby, Chiara Rusconi, Martine E.D. Chamuleau, Harald Holte, Sandra Lockmer, Silvia Montoto, María Gomes da Silva, Igor Aurer, Emanuele Zucca, Ewa Paszkiewicz‐Kozik, Carla Minoia, Tetiana Skrypets, Yngvild Nuvin Blaker, Gilles Salles, Bertrand Coiffier - The Lancet Haematology 2018 cited by 116

  15. Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study

    Authors: Stefano Luminari, Martina Manni, Sara Galimberti, Annibale Versari, Alessandra Tucci, Carola Boccomini, Lucia Farina, Jacopo Olivieri, Luigi Marcheselli, Luca Guerra, Simone Ferrero, Luca Arcaini, Federica Cavallo, Sofya Kovalchuk, Tetiana Skrypets, Ilaria Del Giudice, Stéphane Chauvie, Caterina Patti, Caterina Stelitano, Francesca Ricci, Antonio Pinto, Gloria Margiotta Casaluci, Vittorio Ruggero Zilioli, A Merli, Marco Ladetto, Silvia Bolis, Vincenzo Pavone, Annalisa Chiarenza, Annalisa Arcari, Antonella Anastasia, Alessandra Dondi, Donato Mannina, Massimo Federico, on behalf of Fondazione Italiana Linfomi - Journal of Clinical Oncology 2021 cited by 92

  16. Multicenter Surveillance of Women at High Genetic Breast Cancer Risk Using Mammography, Ultrasonography, and Contrast-Enhanced Magnetic Resonance Imaging (the High Breast Cancer Risk Italian 1 Study)

    Authors: Francesco Sardanelli, Franca Podo, Filippo Santoro, Siranoush Manoukian, S Bergonzi, Giovanna Trecate, Daniele Vergnaghi, Massimo Federico, Laura Cortesi, Stefano Corcione, Sandro Morassut, C. Di Maggio, A Cilotti, Laura Martincich, Massimo Calabrese, Chiara Zuiani, Lorenzo Preda, Bernardo Bonanni, Luca Alessandro Carbonaro, Alma Contegiacomo, Pietro Panizza, Ernesto Di Cesare, Antonella Savarese, M Crecco, Daniela Turchetti, M. Tonutti, Paolo Belli, Alessandro Del Maschio - Investigative Radiology 2010 cited by 337

  17. Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project

    Authors: Christopher P. Fox, Monica Civallero, Young-Hyeh Ko, Martina Manni, Tetiana Skrypets, Stefano Pileri, Seok Jin Kim, María Elena Cabrera, Andrei R. Shustov, Carlos Chiattone, Steven M. Horwitz, Iván Dlouhy, Michele Spina, Felicitas Hitz, Silvia Montoto, Arnon Nagler, Virginia Martínez, Cármino Antônio De Souza, Rubén Fernández-Álvarez, Veronika Ballová, Raúl Gabus, Giorgio Inghirami, Massimo Federico, Won Seog Kim - The Lancet Haematology 2020 cited by 136

  18. Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project

    Authors: Ranjana H. Advani, Tetiana Skrypets, Monica Civallero, Michael A. Spinner, Martina Manni, Won-Seog Kim, Andrei R. Shustov, Steven M. Horwitz, Felicitas Hitz, María Elena Cabrera, Iván Dlouhy, José Vassallo, Stefano Pileri, Giorgio Inghirami, Silvia Montoto, Umberto Vitolo, John Radford, Julie M. Vose, Massimo Federico - Blood 2021 cited by 124

  19. Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: Dennis A. Eichenauer, Andreas Engert, M. André, Massimo Federico, Tim Illidge, Martin Hutchings, Marco Ladetto - Annals of Oncology 2014 cited by 476

  20. Clinicopathologic Characteristics of Angioimmunoblastic T-Cell Lymphoma: Analysis of the International Peripheral T-Cell Lymphoma Project

    Authors: Massimo Federico, Thomas Rüdiger, Monica Bellei, Bharat N. Nathwani, Stefano Luminari, Bertrand Coiffier, Nancy L. Harris, Elaine S. Jaffe, Stefano Pileri, Kerry J. Savage, Dennis D. Weisenburger, Jamés O. Armitage, Nicholas Mounier, Julie M. Vose - Journal of Clinical Oncology 2012 cited by 361

  21. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project

    Authors: Jan Delabie, Harald Holte, Julie M. Vose, Fred Ullrich, Elaine S. Jaffe, Kerry J. Savage, Joseph M. Connors, Lisa M. Rimsza, Nancy L. Harris, Konrad Müller-Hermelink, Thomas Rüdiger, Bertrand Coiffier, Randy D. Gascoyne, Françoise Berger, Kensei Tobinai, Wing Y. Au, Raymond Liang, Emili Montserrat, Ephraim P. Hochberg, Stefano Pileri, Massimo Federico, Bharat N. Nathwani, Jamés O. Armitage, Dennis D. Weisenburger - Blood 2011 cited by 360

  22. Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study

    Authors: Tadeusz Robak, Jie Jin, Halyna Pylypenko, Gregor Verhoef, Noppadol Siritanaratkul, Johannes Drach, Markus Raderer, Jiřı́ Mayer, Juliana Pereira, Gayane Tumyan, Rumiko Okamoto, Susumu Nakahara, Peter Hu, Carlos Appiani, Sepideh Nemat, Franco Cavalli, Achiel Van Hoof, Adriana Sheliga, Adriana Teixeira, Akihiro Tomita, Albert Oriol Rocafiguera, А. Н. Суворов, Alexy Kuzmin, Ali Khojasteh, Amel Mézlini, А К Голенков, André Bosly, Andrew R. Belch, Ann Van de Velde, Arpád Illés, Ashis Mukhopadhyay, Balkis Meddeb, Bernard De Prijck, Bernardo Garichochea, Bülent Ündar, Caballero Gabarrón, Carmen Cao, Cármino Antônio De Souza, Charles M. Farber, Cheol Won Suh, C Burcoveanu, C. Cebotaru, Cristina-Ligia Truica, Dai Maruyama, David Belada, Dina Ben Yehuda, Dmitry Udovitsa, Dolores, Enrica Morra, E. Späth‐Schwalbe, Eva González‐Barca, Evgenii A. Osmanov, Francisco Capote, Fritz Offner, Gálvez Cárdenas, Georg Heß, Georgii Manikhas, Govind Babu, Grigoriy Rekhtman, Guiseppe Rossi, Herlander Marques, Horia Bumbea, Huaqing Wang, Huiqiang Huang, Ilseung Choi, Irina Bulavina, Irina B. Lysenko, Irit Avivi, Iryna Kryachok, Jan Maciej Zaucha, Jan Novák, Joaquín Díaz, Judit Demeter, Julia Alexeeva, Jun Zhu, Kateryna Vilchevskaya, Kenichi Ishizawa, Kenny Mauricio, Kensei Tobinai, Kiyoshi Ando, Kudrat Abdulkadryrov, Lee‐Yung Shih, Lyudmila Kuzina, Mahmut Gümüş, Maike de Wit, Marcelo Capra, Margarida Marques, Marina Golubeva, Mario Ojeda‐Uribe, Maryna Kyselyova, Masafumi Taniwaki, Massimo Federico, Michael Crump, Michele Baccarani, Michinori Ogura, Miklós Egyed, M. Udvardy, Mitsutoshi Kurosawa, Naokuni Uike, Nuriet K. Khuageva and 43 more - The Lancet Oncology 2018 cited by 140

  23. KIT and PDGFRA Mutations and the Risk of GI Stromal Tumor Recurrence

    Authors: Heikki Joensuu, Piotr Rutkowski, Toshirou Nishida, Sonja E. Steigen, Peter Brabec, Lukáš Plank, Bengt Nilsson, Chiara Braconi, Andrea Bordoni, Magnús K. Magnússon, Jozef Šufliarský, Massimo Federico, Jón G. Jónasson, Isabelle Hostein, Pierre‐Paul Bringuier, Jean-François Emile - Journal of Clinical Oncology 2015 cited by 173

  24. The role of autologous stem cell transplantation in patients with nodal peripheral T‐cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study

    Authors: Steven I. Park, Steven M. Horwitz, Francine M. Foss, Lauren Pinter‐Brown, Kenneth R. Carson, Steven T. Rosen, Barbara Pro, Eric D. Hsi, Massimo Federico, Christian Gisselbrecht, Marc Schwartz, Lisa A. Bellm, Mark Acosta, Ranjana H. Advani, Tatyana Feldman, Mary Jo Lechowicz, Sonali M. Smith, Frederick Lansigan, Anil Tulpule, Michael Craig, John P. Greer, Brad S. Kahl, Joseph W. Leach, Neil Morganstein, Carla Casulo, Andrei R. Shustov, for the COMPLETE Investigators - Cancer 2019 cited by 146